Efficacy of Oral Administration of Trehalose in Patients With Parkinson Disease
NCT05355064
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
Trehalose
Sponsor
Neuromed IRCCS